ROUMELL ASSET MANAGEMENT LLC
Q2 2021 Form 13-F
CHEVY CHASE, MARYLAND
CIK 0001331693
· CRD 114057
· SEC-registered investment adviser
$85.6M Reported Value Total
ROUMELL ASSET MANAGEMENT, LLC reports 93 total accounts under management (AUM). There are 93 discretionary accounts valued at $125,281,913, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered
Discretionary Manager
Source: Form ADV filed 2024-03-26
Reported value
$85.6M
Quarter over quarter
-0.7%
Holdings
18
Top-10 concentration
82.6%
Key People
Form ADV owners & control persons
James Christopher Roumell
PRESIDENT/PORTFOLIO MANAGER/MANAGING MEMBER
Craig L Lukin
CHIEF OPERATING OFFICER/CHIEF COMPLIANCE OFFICER/MEMBER
Edward Alexander Crawford
MEMBER
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q2 2021 13F record
Q2 2021 13F filing summary
| Period of report | June 30, 2021 |
|---|---|
| Filed | August 13, 2021 |
| Form | 13F-HR |
| Reported value | $85.6M |
| Positions | 18 |
| Change in reported value | +23.8% |
| New positions | 6 |
| Exited positions | 2 |
| Position turnover | 40.0% |
| Top-10 concentration | 82.6% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2024 13F
Filed Aug 13, 2024
|
16 | $53.3M |
|
Q1 2024 13F
Filed May 14, 2024
|
17 | $53.1M |
|
Q4 2023 13F
Filed Feb 13, 2024
|
15 | $46.5M |
|
Q3 2023 13F
Filed Nov 13, 2023
|
19 | $49.7M |
|
Q2 2023 13F
Filed Aug 11, 2023
|
22 | $50.9M |
|
Q1 2023 13F
Filed May 12, 2023
|
20 | $44.2M |
|
Q4 2022 13F
Filed Feb 13, 2023
|
21 | $40.4M |
|
Q3 2022 13F
Filed Nov 10, 2022
|
21 | $46.2M |
|
Q2 2022 13F
Filed Aug 12, 2022
|
21 | $51.4M |
|
Q1 2022 13F
Filed May 13, 2022
|
19 | $61.9M |
|
Q4 2021 13F
Filed Feb 11, 2022
|
21 | $75.0M |
|
Q3 2021 13F
Filed Nov 12, 2021
|
17 | $75.5M |
|
Q2 2021 13F
Filed Aug 13, 2021
|
18 | $85.6M |
|
Q1 2021 13F
Filed May 14, 2021
|
14 | $69.2M |
|
Q4 2020 13F
Filed Feb 16, 2021
|
16 | $63.6M |
|
Q3 2020 13F
Filed Nov 13, 2020
|
14 | $50.4M |
|
Q2 2020 13F
Filed Aug 14, 2020
|
20 | $41.5M |
|
Q1 2020 13F
Filed May 14, 2020
|
22 | $36.5M |
|
Q4 2019 13F
Filed Feb 14, 2020
|
21 | $43.7M |
|
Q3 2019 13F
Filed Nov 13, 2019
|
14 | $42.3M |
25 earlier quarters on file — choose one from the quarter menu above.
Top 18 holdings · Q2 2021
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | CLGN COLLPLANT BIOTECHNOLOGIES LT | $11.9M | 13.95% |
| 2 | GSIT GSI TECHNOLOGY INC | $10.6M | 12.33% |
| 3 | ALLT ALLOT LTD | $9.9M | 11.59% |
| 4 | ENZB ENZO BIOCHEM INC | $9.2M | 10.69% |
| 5 | QMCO QUANTUM CORP | $7.1M | 8.25% |
| 6 | OPRA OPERA LTD | $6.0M | 6.97% |
| 7 | BCDA BIOCARDIA INC | $5.0M | 5.83% |
| 8 | ESGC EROS STX GLOBAL CORPORATION | $3.9M | 4.56% |
| 9 | SWIR SIERRA WIRELESS INC | $3.8M | 4.45% |
| 10 | MGNI MAGNITE INC | $3.4M | 3.95% |
| 11 | STRM STREAMLINE HEALTH SOLUTIONS | $3.4M | 3.92% |
| 12 | VERO VENUS CONCEPT INC | $2.7M | 3.2% |
| 13 | EXTN EXTERRAN CORP | $2.2M | 2.61% |
| 14 | ARDS ARIDIS PHARMACEUTICALS INC | $2.0M | 2.36% |
| 15 | NODK NI HLDGS INC | $1.6M | 1.82% |
| 16 | CLMB WAYSIDE TECHNOLOGY GROUP INC | $1.5M | 1.76% |
| 17 | RIBT RICEBRAN TECHNOLOGIES | $1.3M | 1.5% |
| 18 | TRAK PARK CITY GROUP INC | $228.0K | 0.27% |
Values as reported on the Q2 2021 Form 13F. Every position is in the holdings table below.